Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)
Clinical trial NCT04655313 · COMPLETED
Trial details
- NCT number
- NCT04655313
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2022-01-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.